DD216023A5 - Verfahren zur herstellung von a-ristomycin und/oder ristomycin-derivaten hoher reinheit - Google Patents

Verfahren zur herstellung von a-ristomycin und/oder ristomycin-derivaten hoher reinheit Download PDF

Info

Publication number
DD216023A5
DD216023A5 DD83255014A DD25501483A DD216023A5 DD 216023 A5 DD216023 A5 DD 216023A5 DD 83255014 A DD83255014 A DD 83255014A DD 25501483 A DD25501483 A DD 25501483A DD 216023 A5 DD216023 A5 DD 216023A5
Authority
DD
German Democratic Republic
Prior art keywords
ristomycin
alpha
solution
group
hydrogen atom
Prior art date
Application number
DD83255014A
Other languages
German (de)
English (en)
Inventor
Kalman Rak
Zoltan Boda
Rezsoe Bognar
Ferenc Sztaricskai
Gabriella Zajka
Original Assignee
Reanal Finomvegyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reanal Finomvegyszergyar filed Critical Reanal Finomvegyszergyar
Publication of DD216023A5 publication Critical patent/DD216023A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/755—Factors VIII, e.g. factor VIII C [AHF], factor VIII Ag [VWF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD83255014A 1982-09-21 1983-09-21 Verfahren zur herstellung von a-ristomycin und/oder ristomycin-derivaten hoher reinheit DD216023A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU823020A HU186121B (en) 1982-09-21 1982-09-21 Process for producing a-ristomycin and/or ristomycin derivative of high purity,and reagent for thrombicyte-aggregation tests containing them

Publications (1)

Publication Number Publication Date
DD216023A5 true DD216023A5 (de) 1984-11-28

Family

ID=10962138

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83255014A DD216023A5 (de) 1982-09-21 1983-09-21 Verfahren zur herstellung von a-ristomycin und/oder ristomycin-derivaten hoher reinheit

Country Status (7)

Country Link
AT (1) AT381709B (fi)
CS (1) CS268796B2 (fi)
DD (1) DD216023A5 (fi)
DE (1) DE3334170A1 (fi)
FI (1) FI76090C (fi)
HU (1) HU186121B (fi)
NO (1) NO166790C (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0186476A3 (en) * 1984-12-21 1987-10-21 Hemochek Corporation Diagnostic kit and method for assaying blood components
DE10013377A1 (de) 2000-03-17 2001-09-20 Dade Behring Marburg Gmbh Induzierte Aggregation und Agglutination von Plättchen

Also Published As

Publication number Publication date
FI833388A (fi) 1984-03-22
ATA335983A (de) 1986-04-15
HU186121B (en) 1985-06-28
CS268796B2 (en) 1990-04-11
FI76090C (fi) 1988-09-09
NO833396L (no) 1984-03-22
NO166790B (no) 1991-05-27
FI76090B (fi) 1988-05-31
CS688183A2 (en) 1989-09-12
AT381709B (de) 1986-11-25
NO166790C (no) 1991-09-04
DE3334170A1 (de) 1984-03-22
FI833388A0 (fi) 1983-09-21

Similar Documents

Publication Publication Date Title
DE60003509T2 (de) Herstellung von nicht-kristallinen und kristallinen Dihydratformen von Azithromycin
DE69103755T2 (de) Wachstumshormonkristalle und verfahren zu deren herstellung.
EP0133674A1 (de) Neue Nitroxylverbindungen, Verfahren zu deren Herstellung und diese enthaltende diagnostische Mittel
DE29622959U1 (de) Analoge des Lachs-Calcitonin
EP0095682A2 (de) Verfahren zur Herstellung zell- und geweberegenerierender Stoffe
DE69818823T2 (de) Dipohosphonsäuresalze für die behandlung von osteoporose
AT398204B (de) Mono-(2-ammonium-2-hydroxymethyl-1,3-propandiol (2r,cis)-1,2-epoxypropylphosphonat und verfahren zu dessen herstellung sowie pharmazeutische zusammensetzungen
DD216023A5 (de) Verfahren zur herstellung von a-ristomycin und/oder ristomycin-derivaten hoher reinheit
DE69917282T2 (de) Verfahren zur herstellung von zofenopril-calciumsalz
DE3650445T2 (de) Verfahren um 1-sesamin zu produzieren mittels Pflanenzellkulturen.
DE1620629C3 (de) Verwendung eines Salzes von 2-Merkaptoäthansulf onsäure zur Herstellung von Mukolytica
DE69107098T2 (de) 2'-Deoxy-2'-Methylidenecytidin-dihydrat, Verfahren zu ihrer Herstellung und Mischmaterial.
EP0119990B1 (de) Verfahren zur Herstellung von therapeutisch verabreichbaren, in Endbehältern abgefüllten Plasmaderivaten
DE2706548A1 (de) Amide der pseudomonsaeure, verfahren zu ihrer herstellung und ihre verwendung
DE68903670T2 (de) Physiologisch aktive, fluessige, allergenische zusammensetzungen aus biologischen rohmaterialien.
DE3212817C2 (fi)
DE2632115C2 (fi)
DE60112482T2 (de) Verbindungen mit antioxidierender Wirkung, diese enthaltende Zusammensetzungen zur Nahrungsmittelergänzung sowie Verfahren zu deren Herstellung
DE2901667A1 (de) Pharmazeutische verwendung von dipeptiden
DE1185335B (de) Verfahren zur Herstellung von neuen Staphylococcen-Antigenen
DE69910810T2 (de) Natriumsalz von 3-(4-cinnamyl-1-piperazinyl)-iminomethyl-rifamycin sv und verfahren zu seiner herstellung
DE2459515C3 (de) Arzneimittelzubereitungen mit antidiabetischer Wirkung
DE2609533B2 (de) Verfahren zur Extraktion von Wirkstoffen, insbesondere von Heterosidestern der Kaffeesäure, sowie diese Verbindungen enthaltende Arzneimittel
DE1911240A1 (de) Neues Antibioticum und seine Herstellung
DE2854041A1 (de) Antibiotisch wirksame verbindungen und deren anwendung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee